GHK-Cu is a copper-binding peptide investigated for protective effects in COPD and lung fibrosis research
It may be beneficial for individuals dealing with concussions, traumatic brain injuries (TBI), and neurological disorders
NICE guidance on obesity management (CG189) emphasises evidence-based interventions including dietary modification, increased physical activity, behavioural therapy, andwhere appropriatepharmacotherapy with licensed medications such as orlistat or semaglutide (NICE TA875)
As a stable, high-purity research peptide, it is studied for tissue regeneration, connective tissue and cartilage repair, mucosal and gastrointestinal tract models, nerve damage, and its bioactive effects on growth factor signalling and collagen